Literature DB >> 6117007

Delta-Aminolaevulinic acid and amino acid neurotransmitters.

M J Brennan, R C Cantrill.   

Abstract

The effects of the porphyrin precursor delta-aminolaevulinic acid (ALA) on gamma-aminobutyric acid (GABA) and L-glutamate transmitter systems was investigated in rat brain. It was found that ALA inhibited GABA and glutamate uptake and stimulated basal efflux of the amino acids in purified nerve endings. These effects were evident only at relatively high concentrations of ALA (at least 100 microM). Such concentrations probably do not occur in the nervous systems of patients suffering from acute porphyria. In addition, it was found that ALA inhibited the stimulated release of GABA from nerve endings probably by acting as an agonist at GABA autoreceptors. This effect was found at very low concentrations of ALA (1 microM). It is therefore likely that the neuropsychiatric manifestations of the acute porphyric attack are attributable, to some extent, to reduced GABA release at central synapses.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6117007     DOI: 10.1007/bf00235687

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  66 in total

Review 1.  Acute intermittent porphyria: clinical and selected research aspects.

Authors:  D P Tschudy; M Valsamis; C R Magnussen
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

2.  The effect of DABA and beta-alanine on the efflux of [3H] GABA from preloaded rat brain synaptosomes.

Authors:  M J Brennan; R C Cantrill
Journal:  J Neurochem       Date:  1978-11       Impact factor: 5.372

3.  Effect of delta-aminolaevulinic acid on the resting membrane potential of frog sartorius muscle.

Authors:  D M Becker; N Goldstuck; S Kramer
Journal:  S Afr Med J       Date:  1975-10-11

4.  Acute intermittent porphyria: a study of 50 cases.

Authors:  A GOLDBERG
Journal:  Q J Med       Date:  1959-04

5.  Tissue uptake of o-aminolaevulinic acid.

Authors:  F B McGillion; G G Thompson; A Goldberg
Journal:  Biochem Pharmacol       Date:  1975-01-15       Impact factor: 5.858

6.  Effects of hematin in hepatic porphyria. Further studies.

Authors:  G J Dhar; I Bossenmaier; Z J Petryka; R Cardinal; C J Watson
Journal:  Ann Intern Med       Date:  1975-07       Impact factor: 25.391

7.  Use of 3H-muscimol for GABA receptor studies.

Authors:  S R Snodgrass
Journal:  Nature       Date:  1978-06-01       Impact factor: 49.962

8.  The inhibition of red cell and brain ATPase by delta-aminolaevulinic acid.

Authors:  D Becker; D Viljoen; S Kramer
Journal:  Biochim Biophys Acta       Date:  1971-01-05

9.  Electroencephalographic and behavioral effects of experimental porphyria in the rat.

Authors:  R J Marcus; L Wetterberg; A Yuwiler; W D Winters
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1970-12

10.  Comparative effects of glycerol and dextrose on porphyrin precursor excretion in acute intermittent porphyria.

Authors:  H L Bonkowsky; C R Magnussen; A R Collins; J M Doherty; R A Hess; D P Tschudy
Journal:  Metabolism       Date:  1976-04       Impact factor: 8.694

View more
  6 in total

1.  Proceedings of the British Pharmacological Society. University of Manchester, 13-15 September 1989.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

2.  Proceedings of the British Pharmacological Society. Nottingham, 7th-9th September 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

3.  Are delta-aminolevulinate dehydratase inhibition and metal concentrations additional factors for the age-related cognitive decline?

Authors:  Marília Baierle; Mariele F Charão; Gabriela Göethel; Anelise Barth; Rafael Fracasso; Guilherme Bubols; Elisa Sauer; Sarah C Campanharo; Rafael C C Rocha; Tatiana D Saint'Pierre; Suelen Bordignon; Murilo Zibetti; Clarissa M Trentini; Daiana S Avila; Adriana Gioda; Solange C Garcia
Journal:  Int J Environ Res Public Health       Date:  2014-10-17       Impact factor: 3.390

Review 4.  Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden.

Authors:  J G Wetmur
Journal:  Environ Health Perspect       Date:  1994-09       Impact factor: 9.031

Review 5.  An update of clinical management of acute intermittent porphyria.

Authors:  Elena Pischik; Raili Kauppinen
Journal:  Appl Clin Genet       Date:  2015-09-01

Review 6.  Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution.

Authors:  Miriam Longo; Erika Paolini; Marica Meroni; Paola Dongiovanni
Journal:  Biomedicines       Date:  2022-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.